Opportunity Information: Apply for RFA CA 12 008
Apply for RFA CA 12 008
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Minority Based Community Clinical Oncology Program Groups (U10)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.399 Cancer Control.
- This funding opportunity was created on Jun 8, 2012 and posted on Jun 8, 2012.
- Applicants must submit their applications by Aug 9, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,500,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Minority Based Community Clinical Oncology Program Groups (U10) opportunity (Funding Opportunity Number RFA-CA-12-008) is a National Institutes of Health, National Cancer Institute funding announcement designed to expand access to NCI-sponsored cancer clinical trials for racial and ethnic minority communities. The core idea is to support networks of practicing community oncologists who primarily serve large minority populations, so they can enroll patients and other participants into NCI-approved clinical trials focused on cancer prevention, detection/diagnosis, treatment, and cancer control. By placing clinical research participation closer to where minority patients actually receive care, the program aims to reduce gaps in trial access and speed the spread of evidence-based cancer care innovations into underserved communities.
This FOA funds “Minority Based CCOP Groups†(often shortened to MBCCOP Groups). An MBCCOP Group is essentially a community-based network of oncology practices and affiliated providers that recruits and accrues patients/participants to NCI-approved trials. Importantly, the MBCCOP Groups are not the entities that design the clinical trials. Trial development, overall conduct, data management, statistical analysis, and reporting are handled by “CCOP Research Bases,†which must be located at either an NCI-supported Clinical Cooperative Group or an NCI-designated Cancer Center. In practice, the MBCCOP Groups function as the community-facing enrollment and care-delivery arm of a larger national clinical trials system, helping ensure minority participation in trials that can shape future standards of care.
The MBCCOP program is presented as one component of a broader CCOP Network, which has three distinct parts, each with its own funding announcement: (1) Minority Based CCOP Groups (this FOA), (2) CCOP Groups (general CCOPs), and (3) CCOP Research Bases. This structure is meant to link community practices with major research hubs, creating a pipeline where trial opportunities, protocols, and research findings move efficiently between academic centers and community oncology settings. A central goal is “technology transfer†in the clinical sense: getting the newest prevention, control, and treatment approaches into real-world minority-serving practices more quickly, while also improving the representativeness of trial populations.
The award mechanism is a cooperative agreement (U10), which typically signals substantial programmatic involvement by the federal sponsor compared with a standard research project grant. The funding activity is categorized under Education and Health, and the relevant CFDA numbers span several cancer research areas: 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), and 93.399 (Cancer Control). The announcement anticipated about 8 awards, with an estimated total funding level of $5,500,000, and it explicitly states there is no cost-sharing or matching requirement.
Eligibility is broad across U.S.-based organizations that can support clinical trial accrual infrastructure in minority-serving settings. Eligible applicants include public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations (other than small businesses), Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments), and a range of mission-focused institutions and community entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. Foreign institutions are not eligible, and non-U.S. components of U.S. organizations are not allowed; foreign components as defined by NIH policy are also prohibited.
Administratively, this FOA was posted and created on June 8, 2012, with an original and current closing date of August 9, 2012, and an archive date of September 9, 2012. The full announcement was hosted through the NIH Grants Guide (link provided in the source), and the contact listed for access or technical linking problems is the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the Minority Based Community Clinical Oncology Program Groups (U10) funding opportunity?
It is an NIH National Cancer Institute (NCI) funding opportunity (Funding Opportunity Number RFA-CA-12-008) designed to expand access to NCI-sponsored cancer clinical trials for racial and ethnic minority communities by supporting community-based oncology networks that can enroll patients and other participants into NCI-approved trials.
What is the main goal of this program?
The program aims to reduce gaps in clinical trial access for racial and ethnic minority communities and to speed the spread of evidence-based cancer care innovations into underserved settings by placing clinical research participation closer to where minority patients receive care.
What types of clinical trials are involved?
The supported networks enroll participants into NCI-approved clinical trials focused on cancer prevention, detection/diagnosis, treatment, and cancer control.
What exactly is funded under this FOA?
This FOA funds "Minority Based CCOP Groups" (MBCCOP Groups), which are community-based networks of oncology practices and affiliated providers that recruit and accrue patients/participants to NCI-approved clinical trials.
Do MBCCOP Groups design or run the clinical trials?
No. MBCCOP Groups are not the entities that design the clinical trials. Trial development, overall conduct, data management, statistical analysis, and reporting are handled by CCOP Research Bases.
What is a CCOP Research Base in this program structure?
A CCOP Research Base is responsible for clinical trial development and centralized trial operations (including data management, statistical analysis, and reporting). CCOP Research Bases must be located at either an NCI-supported Clinical Cooperative Group or an NCI-designated Cancer Center.
How do MBCCOP Groups and CCOP Research Bases work together?
MBCCOP Groups serve as the community-facing enrollment and care-delivery arm, connecting minority-serving practices to the larger national clinical trials system, while Research Bases provide the research hub functions for the trials.
How does this FOA fit into the broader CCOP Network?
This program is described as one component of a broader CCOP Network with three distinct parts, each with its own funding announcement: (1) Minority Based CCOP Groups (this FOA), (2) CCOP Groups (general CCOPs), and (3) CCOP Research Bases.
What does "technology transfer" mean in the context of this announcement?
It refers to moving the newest cancer prevention, control, and treatment approaches into real-world minority-serving community practices more quickly by linking community sites to major research hubs and trial opportunities.
What is the award mechanism for this opportunity?
The award mechanism is a cooperative agreement (U10), which typically indicates substantial programmatic involvement by the federal sponsor compared with a standard research project grant.
Which federal agencies are involved?
The funding opportunity is issued by the National Institutes of Health (NIH), National Cancer Institute (NCI).
How is this funding activity categorized?
The funding activity is categorized under Education and Health.
Which CFDA numbers are associated with this opportunity?
The relevant CFDA numbers listed are 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), and 93.399 (Cancer Control).
How many awards were anticipated and what was the estimated total funding?
The announcement anticipated about 8 awards, with an estimated total funding level of $5,500,000.
Is cost-sharing or matching required?
No. The opportunity explicitly states there is no cost-sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad across U.S.-based organizations that can support clinical trial accrual infrastructure in minority-serving settings. Eligible applicants include public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations (other than small businesses), Native American tribal governments (federally recognized), tribal organizations (other than federally recognized tribal governments), and a range of mission-focused institutions and community entities.
Are specific minority-serving institutions mentioned as eligible?
Yes. The eligible entities listed include Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities (TCCUs), as well as faith-based or community-based organizations and regional organizations.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are included in the eligibility list.
Are federal agencies eligible to apply?
Yes. Eligible federal agencies are included in the eligibility list.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible.
Can a U.S. organization include a non-U.S. component?
No. Non-U.S. components of U.S. organizations are not allowed, and foreign components as defined by NIH policy are also prohibited.
When was this FOA posted and created?
The FOA was posted and created on June 8, 2012.
What were the closing date and archive date for this opportunity?
The original and current closing date was August 9, 2012, and the archive date was September 9, 2012.
Where was the full announcement hosted?
The full announcement was hosted through the NIH Grants Guide (a link was provided in the source information).
Who should be contacted for access or technical linking problems?
The contact listed for access or technical linking problems is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
What is the program trying to change about where clinical trial participation happens?
It is designed to bring trial enrollment and participation closer to community oncology practices that primarily serve large minority populations, rather than limiting participation to major academic centers.
What role do community oncologists play in this program?
The core idea is to support networks of practicing community oncologists and affiliated providers so they can enroll patients and other participants into NCI-approved trials.
How does this program aim to improve clinical trial representativeness?
By supporting minority-serving community practice networks as enrollment sites, the program aims to increase minority participation in NCI-approved trials that can shape future standards of care.
Browse more opportunities from the same category: Education Health
Next opportunity: Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (SBIR R43/R44)
Previous opportunity: Community Clinical Oncology Program Groups (U10)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 12 008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 12 008) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIMH Career Transition Award for Tenure Track and Tenured Intramural Investigators (K22) Apply for PAR 12 201 Funding Number: PAR 12 201 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Education Grants for Statistical and Computational Training in the Genetics of Addiction (R25) Apply for PAR 12 199 Funding Number: PAR 12 199 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| U.S. India Bilateral Collaborative Research Partnerships (CRP) on the Prevention of HIV/AIDS and Co morbidities (R21) Apply for RFA AI 12 033 Funding Number: RFA AI 12 033 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Establish Sharing of Human Brain Image Data Relevant to Drug Addiction (Admin Supp) Apply for PAR 12 204 Funding Number: PAR 12 204 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 13 008 Funding Number: RFA DA 13 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Identifying Non coding RNA Targets for Early Detection of Cancer (R01) Apply for PA 12 213 Funding Number: PA 12 213 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Identifying Non coding RNA Targets for Early Detection of Cancer (R21) Apply for PA 12 214 Funding Number: PA 12 214 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R21) Apply for PA 12 220 Funding Number: PA 12 220 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R01) Apply for PA 12 221 Funding Number: PA 12 221 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cohort Studies of HIV/AIDS and Substance Use (U01) Apply for PAR 12 222 Funding Number: PAR 12 222 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Advancing Community level Approaches to Reduce HIV Infection in Highly Impacted Communities (R01) Apply for RFA MH 13 090 Funding Number: RFA MH 13 090 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Advancing Community level Approaches to Reduce HIV Infection in Highly Impacted Communities (R21) Apply for RFA MH 13 091 Funding Number: RFA MH 13 091 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Community level Approaches to Reduce HIV Infection in Highly Impacted Communities (R34) Apply for RFA MH 13 092 Funding Number: RFA MH 13 092 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Addressing Needs of Informal Caregivers of Individuals with Alzheimers Disease in the Context of Sociodemographic Factors (R01) Apply for RFA NR 13 001 Funding Number: RFA NR 13 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Physical activity and weight control interventions among cancer survivors Effects on biomarkers of prognosis and survival (R01) Apply for PAR 12 228 Funding Number: PAR 12 228 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical activity and weight control interventions among cancer survivors Effects on biomarkers of prognosis and survival (R21) Apply for PAR 12 229 Funding Number: PAR 12 229 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Translational Research on Interventions for Adolescents in the Legal System TRIALS (U01) Apply for RFA DA 13 009 Funding Number: RFA DA 13 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Development of Minimally Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21) Apply for PAR 12 238 Funding Number: PAR 12 238 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Clinical Development of Minimally Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01) Apply for PAR 12 239 Funding Number: PAR 12 239 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| NCI National Clinical Trials Network Network Radiotherapy and Imaging Core Services Centers (U24) Apply for RFA CA 12 014 Funding Number: RFA CA 12 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 12 008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.